Severe Autoimmune Diseases View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2020-07-01

AUTHORS

Melanie Henes , Michael von Wolff , Joerg Henes

ABSTRACT

This section deals with ovarian protection in non-malignant, rheumatic or other autoimmune diseases. Since these diseases are disproportionately common in young women, knowledge of the negative effects of immunosuppressive agents on the ovarian reserve, as well as the possibilities and limitations of ovarian protective measures, even in this particular patient population, is essential. According to current data, we should offer patients at increased risk of POI treatment with GnRH analogues when using cyclophosphamide. In addition, the use of ovarian cryopreservation (short time frame, sufficiently high ovarian reserve) should be generously considered. Ovarian stimulation therapy is only advisable in rare cases, as many patients are at risk of exacerbation of the underlying disease. More... »

PAGES

123-131

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_15

DOI

http://dx.doi.org/10.1007/978-3-030-47568-0_15

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1128882857


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Gynaecological Endocrinology and Reproductive Medicine, University Women\u2019s Hospital, Tuebingen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411544.1", 
          "name": [
            "Division of Gynaecological Endocrinology and Reproductive Medicine, University Women\u2019s Hospital, Tuebingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Henes", 
        "givenName": "Melanie", 
        "id": "sg:person.01156232223.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156232223.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gynaecological Endocrinology and Reproductive Medicine, University Women\u2019s Hospital, University of Bern, Bern, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.411656.1", 
          "name": [
            "Division of Gynaecological Endocrinology and Reproductive Medicine, University Women\u2019s Hospital, University of Bern, Bern, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "von Wolff", 
        "givenName": "Michael", 
        "id": "sg:person.0610777233.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610777233.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine II (Haematology, Oncology, Immunology and Rheumatology), University Hospital Tuebingen, Tuebingen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411544.1", 
          "name": [
            "Department of Internal Medicine II (Haematology, Oncology, Immunology and Rheumatology), University Hospital Tuebingen, Tuebingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Henes", 
        "givenName": "Joerg", 
        "id": "sg:person.010365700347.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010365700347.66"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2020-07-01", 
    "datePublishedReg": "2020-07-01", 
    "description": "This section deals with ovarian protection in non-malignant, rheumatic or other autoimmune diseases. Since these diseases are disproportionately common in young women, knowledge of the negative effects of immunosuppressive agents on the ovarian reserve, as well as the possibilities and limitations of ovarian protective measures, even in this particular patient population, is essential. According to current data, we should offer patients at increased risk of POI treatment with GnRH analogues when using cyclophosphamide. In addition, the use of ovarian cryopreservation (short time frame, sufficiently high ovarian reserve) should be generously considered. Ovarian stimulation therapy is only advisable in rare cases, as many patients are at risk of exacerbation of the underlying disease.", 
    "editor": [
      {
        "familyName": "von Wolff", 
        "givenName": "Michael", 
        "type": "Person"
      }, 
      {
        "familyName": "Nawroth", 
        "givenName": "Frank", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-030-47568-0_15", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-030-47567-3", 
        "978-3-030-47568-0"
      ], 
      "name": "Fertility Preservation in Oncological and Non-Oncological Diseases", 
      "type": "Book"
    }, 
    "keywords": [
      "autoimmune diseases", 
      "ovarian stimulation therapy", 
      "risk of exacerbations", 
      "severe autoimmune disease", 
      "particular patient population", 
      "POI treatment", 
      "ovarian protection", 
      "ovarian reserve", 
      "underlying disease", 
      "immunosuppressive agents", 
      "ovarian cryopreservation", 
      "GnRH analogues", 
      "patient population", 
      "stimulation therapy", 
      "rare case", 
      "young women", 
      "disease", 
      "patients", 
      "current data", 
      "risk", 
      "protective measures", 
      "cyclophosphamide", 
      "exacerbation", 
      "therapy", 
      "women", 
      "treatment", 
      "population", 
      "agents", 
      "cryopreservation", 
      "negative effects", 
      "cases", 
      "measures", 
      "effect", 
      "protection", 
      "use", 
      "analogues", 
      "data", 
      "addition", 
      "knowledge", 
      "reserves", 
      "sections", 
      "limitations", 
      "possibility"
    ], 
    "name": "Severe Autoimmune Diseases", 
    "pagination": "123-131", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1128882857"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-030-47568-0_15"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-030-47568-0_15", 
      "https://app.dimensions.ai/details/publication/pub.1128882857"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-12-01T06:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/chapter/chapter_37.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-030-47568-0_15"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_15'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_15'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_15'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_15'


 

This table displays all metadata directly associated to this object as RDF triples.

126 TRIPLES      22 PREDICATES      67 URIs      60 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-030-47568-0_15 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author N163b715f6feb4cc78cf1db8152ca6c8c
4 schema:datePublished 2020-07-01
5 schema:datePublishedReg 2020-07-01
6 schema:description This section deals with ovarian protection in non-malignant, rheumatic or other autoimmune diseases. Since these diseases are disproportionately common in young women, knowledge of the negative effects of immunosuppressive agents on the ovarian reserve, as well as the possibilities and limitations of ovarian protective measures, even in this particular patient population, is essential. According to current data, we should offer patients at increased risk of POI treatment with GnRH analogues when using cyclophosphamide. In addition, the use of ovarian cryopreservation (short time frame, sufficiently high ovarian reserve) should be generously considered. Ovarian stimulation therapy is only advisable in rare cases, as many patients are at risk of exacerbation of the underlying disease.
7 schema:editor N0d3c60e7e8f64f0881effd54a1450713
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N20007325a6fc4014be8eb79c132abfd7
11 schema:keywords GnRH analogues
12 POI treatment
13 addition
14 agents
15 analogues
16 autoimmune diseases
17 cases
18 cryopreservation
19 current data
20 cyclophosphamide
21 data
22 disease
23 effect
24 exacerbation
25 immunosuppressive agents
26 knowledge
27 limitations
28 measures
29 negative effects
30 ovarian cryopreservation
31 ovarian protection
32 ovarian reserve
33 ovarian stimulation therapy
34 particular patient population
35 patient population
36 patients
37 population
38 possibility
39 protection
40 protective measures
41 rare case
42 reserves
43 risk
44 risk of exacerbations
45 sections
46 severe autoimmune disease
47 stimulation therapy
48 therapy
49 treatment
50 underlying disease
51 use
52 women
53 young women
54 schema:name Severe Autoimmune Diseases
55 schema:pagination 123-131
56 schema:productId N3d5b279ba3c442ad9dd8754bf05321a8
57 N93d27da11cdb4c049f9902ff83ef3231
58 schema:publisher N78420acba8d34a3db059b75e188f7f2a
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1128882857
60 https://doi.org/10.1007/978-3-030-47568-0_15
61 schema:sdDatePublished 2022-12-01T06:52
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher N9fefc2bde2ff4585961d06cb0c2a1da8
64 schema:url https://doi.org/10.1007/978-3-030-47568-0_15
65 sgo:license sg:explorer/license/
66 sgo:sdDataset chapters
67 rdf:type schema:Chapter
68 N0d3c60e7e8f64f0881effd54a1450713 rdf:first N9534b21b4aaa4c17b2098d7557d0ebce
69 rdf:rest N7f4f6a41c03640aeb1310849550f9e4e
70 N163b715f6feb4cc78cf1db8152ca6c8c rdf:first sg:person.01156232223.05
71 rdf:rest Na59fd4f489bf4fbaae3a40e56469c3bf
72 N20007325a6fc4014be8eb79c132abfd7 schema:isbn 978-3-030-47567-3
73 978-3-030-47568-0
74 schema:name Fertility Preservation in Oncological and Non-Oncological Diseases
75 rdf:type schema:Book
76 N3d5b279ba3c442ad9dd8754bf05321a8 schema:name dimensions_id
77 schema:value pub.1128882857
78 rdf:type schema:PropertyValue
79 N5dd6d5c528804d0e99e75a2641deceb8 rdf:first sg:person.010365700347.66
80 rdf:rest rdf:nil
81 N78420acba8d34a3db059b75e188f7f2a schema:name Springer Nature
82 rdf:type schema:Organisation
83 N7f4f6a41c03640aeb1310849550f9e4e rdf:first N88ca5e5676c548f5b674f90cda0d0eb0
84 rdf:rest rdf:nil
85 N88ca5e5676c548f5b674f90cda0d0eb0 schema:familyName Nawroth
86 schema:givenName Frank
87 rdf:type schema:Person
88 N93d27da11cdb4c049f9902ff83ef3231 schema:name doi
89 schema:value 10.1007/978-3-030-47568-0_15
90 rdf:type schema:PropertyValue
91 N9534b21b4aaa4c17b2098d7557d0ebce schema:familyName von Wolff
92 schema:givenName Michael
93 rdf:type schema:Person
94 N9fefc2bde2ff4585961d06cb0c2a1da8 schema:name Springer Nature - SN SciGraph project
95 rdf:type schema:Organization
96 Na59fd4f489bf4fbaae3a40e56469c3bf rdf:first sg:person.0610777233.66
97 rdf:rest N5dd6d5c528804d0e99e75a2641deceb8
98 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
99 schema:name Medical and Health Sciences
100 rdf:type schema:DefinedTerm
101 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
102 schema:name Immunology
103 rdf:type schema:DefinedTerm
104 sg:person.010365700347.66 schema:affiliation grid-institutes:grid.411544.1
105 schema:familyName Henes
106 schema:givenName Joerg
107 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010365700347.66
108 rdf:type schema:Person
109 sg:person.01156232223.05 schema:affiliation grid-institutes:grid.411544.1
110 schema:familyName Henes
111 schema:givenName Melanie
112 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156232223.05
113 rdf:type schema:Person
114 sg:person.0610777233.66 schema:affiliation grid-institutes:grid.411656.1
115 schema:familyName von Wolff
116 schema:givenName Michael
117 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610777233.66
118 rdf:type schema:Person
119 grid-institutes:grid.411544.1 schema:alternateName Department of Internal Medicine II (Haematology, Oncology, Immunology and Rheumatology), University Hospital Tuebingen, Tuebingen, Germany
120 Division of Gynaecological Endocrinology and Reproductive Medicine, University Women’s Hospital, Tuebingen, Germany
121 schema:name Department of Internal Medicine II (Haematology, Oncology, Immunology and Rheumatology), University Hospital Tuebingen, Tuebingen, Germany
122 Division of Gynaecological Endocrinology and Reproductive Medicine, University Women’s Hospital, Tuebingen, Germany
123 rdf:type schema:Organization
124 grid-institutes:grid.411656.1 schema:alternateName Division of Gynaecological Endocrinology and Reproductive Medicine, University Women’s Hospital, University of Bern, Bern, Switzerland
125 schema:name Division of Gynaecological Endocrinology and Reproductive Medicine, University Women’s Hospital, University of Bern, Bern, Switzerland
126 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...